MARTHA RIDLEY: Open Payments
NPI 1720410327 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 60 payments from 19 companies in 2025. Trend: 2023 $1,024 · 2024 $939 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $401 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| PFIZER INC. | 4 | $63 |
| Novo Nordisk Inc | 4 | $59 |
| Lilly USA, LLC | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Amgen Inc. | 3 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $36 |
Products named: QULIPTA, UBRELVY, REXULTI, VRAYLAR, CAPLYTA, ELIQUIS, MOUNJARO, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
